HomeCompareAIMC vs JNJ

AIMC vs JNJ: Dividend Comparison 2026

AIMC yields 0.58% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $10.7K in total portfolio value· pulled ahead in Year 5
10 years
AIMC
AIMC
● Live price
0.58%
Share price
$61.98
Annual div
$0.36
5Y div CAGR
-48.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.8K
Annual income
$0.08
Full AIMC calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — AIMC vs JNJ

📍 JNJ pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAIMCJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AIMC + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AIMC pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AIMC
Annual income on $10K today (after 15% tax)
$49.37/yr
After 10yr DRIP, annual income (after tax)
$0.07/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JNJ beats the other by $4,037.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AIMC + JNJ for your $10,000?

AIMC: 50%JNJ: 50%
100% JNJ50/50100% AIMC
Portfolio after 10yr
$25.1K
Annual income
$2,374.98/yr
Blended yield
9.45%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AIMC
Analyst Ratings
4
Buy
7
Hold
Consensus: Hold
Price Target
$58.00
-6.4% upside vs current
Range: $58.00 — $58.00
Altman Z
2.5
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AIMC buys
0
JNJ buys
0
No recent congressional trades found for AIMC or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAIMCJNJ
Forward yield0.58%2.14%
Annual dividend / share$0.36$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-48.1%28%
Portfolio after 10y$19.8K$30.5K
Annual income after 10y$0.08$4,749.88
Total dividends collected$63.00$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$58.00$228.73

Year-by-year: AIMC vs JNJ ($10,000, DRIP)

YearAIMC PortfolioAIMC Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,730$30.15$10,594$274.49+$136.00AIMC
2$11,497$15.69$11,294$360.69+$203.00AIMC
3$12,310$8.15$12,133$476.91+$177.00AIMC
4$13,176$4.23$13,156$635.42+$20.00AIMC
5← crossover$14,100$2.20$14,432$854.61$332.00JNJ
6$15,088$1.14$16,056$1,162.76$968.00JNJ
7$16,145$0.59$18,175$1,604.53$2.0KJNJ
8$17,276$0.31$21,009$2,252.68$3.7KJNJ
9$18,485$0.16$24,911$3,229.73$6.4KJNJ
10$19,779$0.08$30,458$4,749.88$10.7KJNJ

AIMC vs JNJ: Complete Analysis 2026

AIMCStock

Altra Industrial Motion Corp. designs, produces, and markets a range of electromechanical power transmission motion control products for use in various motion-related applications, and high-volume manufacturing and non-manufacturing processes. The company operates in two segments, Power Transmission Technologies (PTT) and Automation & Specialty (A&S). The PTT segment offers couplings, such as gear couplings, diaphragm and disc couplings, elastomeric couplings, miniature and precision couplings, universal joints, mill spindles, and shaft locking devices under the Ameridrives, Bibby, Guardian, Huco, Lamiflex, Stromag, and TB Wood's brands; clutches and brakes under the Industrial Clutch, Formsprag, Stieber, Stromag, Svendborg, Twiflex, and Wichita brands; electromagnetic clutches and brakes under the Inertia Dynamics, Matrix, Stromag, and Warner Electric brands; and gears under the Bauer Gear Motor, Boston Gear, Delroyd, and Nuttall brands. The A&S segment provides rotary precision motion solutions, including servo and stepper motors, precision linear actuators, and electronic drives and motion controllers, as well as related software under the Kollmorgen brand; and miniature motors, and motion control products, such as brush and brushless DC, can stack, and disc magnet motors under the Portescap brand. This segment also offers linear bearings, guides, glides, lead and ball screws, industrial linear actuators, resolvers, and inductors for the transition of rotary motion to linear motion under the Thomson and Nook brands. It serves in North America, the rest of Europe, Germany, China, the rest of Asia, and internationally. The company was formerly known as Altra Holdings, Inc. and changed its name to Altra Industrial Motion Corp. in November 2013. Altra Industrial Motion Corp. was incorporated in 2004 and is headquartered in Braintree, Massachusetts. As of March 27, 2023, Altra Industrial Motion Corp. operates as a subsidiary of Regal Rexnord Corporation.

Full AIMC Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this AIMC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AIMC vs SCHDAIMC vs JEPIAIMC vs OAIMC vs KOAIMC vs MAINAIMC vs ABBVAIMC vs MRKAIMC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.